You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR BIPERIDEN LACTATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for biperiden lactate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01048138 ↗ Use of Biperiden for the Prevention of Post-traumatic Epilepsy Recruiting Cristália Produtos Químicos Farmacêuticos Ltda. Phase 3 2018-01-31 There is no AED or medication that has been demonstrated to affect the development of post-traumatic epilepsy. Biperiden is a cholinergic antagonist, acting in the muscarinic receptor, that is widely used as an anti Parkinson drug. The investigators data with animal models of epilepsy indicate that anti-muscarinic agents might affect the natural course of the disease in the case of post-traumatic epilepsy.
NCT01048138 ↗ Use of Biperiden for the Prevention of Post-traumatic Epilepsy Recruiting University of Sao Paulo Phase 3 2018-01-31 There is no AED or medication that has been demonstrated to affect the development of post-traumatic epilepsy. Biperiden is a cholinergic antagonist, acting in the muscarinic receptor, that is widely used as an anti Parkinson drug. The investigators data with animal models of epilepsy indicate that anti-muscarinic agents might affect the natural course of the disease in the case of post-traumatic epilepsy.
NCT01048138 ↗ Use of Biperiden for the Prevention of Post-traumatic Epilepsy Recruiting Federal University of São Paulo Phase 3 2018-01-31 There is no AED or medication that has been demonstrated to affect the development of post-traumatic epilepsy. Biperiden is a cholinergic antagonist, acting in the muscarinic receptor, that is widely used as an anti Parkinson drug. The investigators data with animal models of epilepsy indicate that anti-muscarinic agents might affect the natural course of the disease in the case of post-traumatic epilepsy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for biperiden lactate

Condition Name

Condition Name for biperiden lactate
Intervention Trials
Traumatic Brain Injury 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for biperiden lactate
Intervention Trials
Wounds and Injuries 1
Epilepsy, Post-Traumatic 1
Brain Injuries, Traumatic 1
Brain Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for biperiden lactate

Trials by Country

Trials by Country for biperiden lactate
Location Trials
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for biperiden lactate

Clinical Trial Phase

Clinical Trial Phase for biperiden lactate
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for biperiden lactate
Clinical Trial Phase Trials
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for biperiden lactate

Sponsor Name

Sponsor Name for biperiden lactate
Sponsor Trials
Cristália Produtos Químicos Farmacêuticos Ltda. 1
University of Sao Paulo 1
Federal University of São Paulo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for biperiden lactate
Sponsor Trials
Other 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.